Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States

Hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) is an autosomal dominantly inherited syndrome predisposing to the early development of cancers of the colon, rectum, endometrium, small bowel, and urinary tract and accounts for ∼5% of all colon cancer cases.1 There are at least five genes involved in this cancer predisposition and they include MLH1 ,2 MSH2 ,3 MSH6 ,4 PMS2 , and PMS1 .5 Currently, more than 300 different mutations have been described in these genes which account for approximately 500 HNPCC kindreds from different parts of the world.6 MLH1 and MSH2 genes show abnormalities in more than 90% of HNPCC families with identified germline mutations7 (http://www.nfdht.nl). The majority of reported MLH1 and MSH2 mutations are dispersed throughout the 35 exons of these two genes. However, some changes are recurrent and are described as founder mutations in particular populations.8–11 In order to develop efficient DNA testing, it is important to describe the nature and frequency of mutations that are characteristic of particular ethnic groups. The MSH2 and MLH1 mutation spectrum has not been investigated in the eastern European region and therefore there is no knowledge about any recurrent mutations which may significantly aid in the mutation screening procedures for this region. Here, we describe the results of DNA/RNA based mutation sequencing of both the MSH2 and MLH1 genes in a series of HNPCC families from Poland (89 cases) and the Baltic States (12 cases). ### Patients A total of 101 unrelated patients affected by colorectal cancer or an HNPCC associated cancer (endometrium, small bowel, urinary tract) were from 17 families which fulfilled the Amsterdam II criteria12 and from 84 families matching our modified criteria of suspected HNPCC, one colorectal cancer patient with a first degree relative affected by an HNPCC associated cancer, …

[1]  J. Kładny,et al.  Nuclear Pedigree Criteria of Suspected HNPCC , 2003, Hereditary Cancer in Clinical Practice.

[2]  R. Scott,et al.  Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. , 2002, Journal of biochemical and biophysical methods.

[3]  A. de la Chapelle,et al.  Genetic susceptibility to non-polyposis colorectal cancer , 1999, Journal of medical genetics.

[4]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[5]  D. Evans,et al.  A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer , 1999, Journal of medical genetics.

[6]  P. Møller,et al.  MSH2 genomic deletions are a frequent cause of HNPCC , 1998, Nature Genetics.

[7]  P. Peltomäki,et al.  Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. , 1997, Gastroenterology.

[8]  Y. Yuasa,et al.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. , 1997, Cancer research.

[9]  J. Rehfeld,et al.  Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression. , 1997, American journal of human genetics.

[10]  A. de la Chapelle,et al.  DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. , 1996, Human molecular genetics.

[11]  K. Kinzler,et al.  Founding mutations and Alu-mediated recombination in hereditary colon cancer , 1995, Nature Medicine.

[12]  Inge,et al.  Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. , 1995, American journal of human genetics.

[13]  R. Kolodner,et al.  Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. , 1995, Cancer research.

[14]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[15]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[16]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[17]  D. Lahiri,et al.  DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality , 1993, Biochemical Genetics.

[18]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.

[19]  P. Peltomäki,et al.  Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations , 2004, Familial Cancer.

[20]  J. Kładny,et al.  Optimization of experimental conditions for RNA‐based sequencing of MLH1 and MSH2 genes , 2001, Human mutation.

[21]  N. Lindor.  Suspected Hereditary Nonpolyposis Colorectal Cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) Criteria and Results of Genetic Diagnosis , 1999 .